NEA Management Company »

Korro Bio shares owned by NEA Management Company

Quarter-by-quarter ownership of Korro Bio (KRRO) shares owned by NEA Management Company from 13F filings

Historical chart of NEA Management Company investment in Korro Bio

Tip: Access up to 7 years of quarterly data

All positions including Korro Bio held by NEA Management Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Korro Bio by NEA Management Company

Quarter filed Position value Share count Share price at filing
2023-12-31 $41M 1.1M 38.34

More positions owned by NEA Management Company

Coursera (COUR)
Arcellx Common Stock (ACLX)
Rhythm Pharmaceuticals (RYTM)
Savara (SVRA)
Verona Pharma Sponsered Ads (VRNA)
Crispr Therapeutics Namen Akt (CRSP)
CVRX (CVRX)
Geron Corporation (GERN)
Monte Rosa Therapeutics (GLUE)
Korro Bio (KRRO)
Nextnav Common Stock (NN)
Aurinia Pharmaceuticals (AUPH)
Nkarta (NKTX)
Bright Health Group Com New (NEUE)
Sagimet Biosciences Com Ser A (SGMT)

View all positions for NEA Management Company

Top funds holding Korro Bio

Atlas Venture Life Science Advisors
NEA Management Company
Eventide Asset Management
Citadel Advisors
Cormorant Asset Management
Artal Group
Qiming U.S. Ventures Management
72 Investment Holdings
Vanguard Group
Point72 Asset Management
Monashee Investment Management
Citigroup
Jane Street
Bank of America Corporation
North Star Investment Management

View all funds holding Korro Bio